Summary
A two-year T32 training program for medical oncology physicians focused on molecular targets for cancer detection and treatment, aiming to develop leaders in molecular oncology research.
Molecular Targets for Cancer Detection and Treatment
US · IL
NIH
grant
awarded
#nih-5T32CA009071-44
What they want
This Molecular Targets Training Program addresses workforce needs for scientifically trained medical oncology physicians who will translate molecular biology knowledge into advances for cancer patients. The two-year T32 program emphasizes critical thinking skills through hands-on projects in a mentored environment. It includes formal didactic requirements, inter-disciplinary work across laboratory-translational boundaries, and expanded learning opportunities in computational biology, grantspersonship, and professional development. The program has a strong track record of trainees transitioning to and advancing in research positions.
Technical requirements
- Hands-on projects
- Supportive mentored environment
- Formalized didactic requirements
- Inter-disciplinary work across laboratory-translational boundaries
- Training in computational biology
- Training in grantspersonship
- Training in professional development
Key personnel
- Program Directors
- Participating faculty (39 mentioned)
Market context
inferred from NAICSEducational Services
NAICS 611310
- US market size
- $340B
- Typical award
- $50K – $25M
Typical buyers
DoDVAStates
Commonly required
Accreditation
Sector-level estimate — full code lookup not yet in catalog.
